Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Operating activities
Net earnings	$ 213	$ 168	$ 405
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	91	85	65
Deferred income taxes	23	(52)	(6)
Gain from sale of business	0	0	(354)
Share-based compensation expense	22	17	5
Other	1	1	0
Changes in assets and liabilities:
Accounts receivable	(102)	15	(1)
Contract assets	36	(36)	(134)
Inventories	(29)	(10)	(33)
Prepaid expenses	(6)	(1)	(1)
Other current assets	(13)	(18)	3
Other noncurrent assets	17	19	24
Defined benefit obligations	(2)	(8)	(4)
Accounts payable	15	(59)	(14)
Contract liabilities	64	102	72
Other current liabilities	(39)	(26)	14
Other noncurrent liabilities	(20)	8	(8)
Net cash provided by operating activities	271	205	33
Investing activities
Capital expenditures	(85)	(60)	(65)
Business acquisitions, net of cash acquired	0	0	19
Proceeds from sales of assets	1	1	0
Proceeds from sales of businesses	0	0	482
Net cash (used in) provided by investing activities	(84)	(59)	436
Financing activities
Net (decrease) increase in third party borrowings (maturities of 90 days or less)	(32)	20	(8)
Repayment of third party debt	(291)	(727)	0
Borrowings of third party debt	280	715	223
Repayment of related party debt	0	0	(992)
Borrowings from related parties	0	0	775
Dividend to US Holding	0	0	(396)
Dividend from investment	0	0	3
Proceeds from stock issuance	16	12	0
Cash outlay to reacquire equity instruments	(19)	(1)	0
Other	(10)	(4)	(8)
Net cash (used in) provided by financing activities	(56)	15	(403)
Effect of exchange rate changes on cash and cash equivalents	0	0	0
Net increase in cash and cash equivalents	131	161	66
Cash and cash equivalents at beginning of year	467	306	240
Cash and cash equivalents at end of year	$ 598	$ 467	$ 306